{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2852, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/C1CBe9OrOco3jWn5j1ok7DVUDz23m7AZklmDoL4kFkY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMGRkNmVhYjE3YjY4MzBiMDIyMjYxNWY0MzkxZTM4Zi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/1", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "efee8b4c-4527-4420-ba04-24096ba129b2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to the presenters and the merger", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": "https://imgproxy.kitesheet.com/SyvSAqMGNVUXM0baLin6wvfAfLeZpll4QyHTwb4qhk8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMGRkNmVhYjE3YjY4MzBiMDIyMjYxNWY0MzkxZTM4Zi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/uCsZaaxJanHFICHklDE5FO1TbHWgZHl_NUW2wmrbhoc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMGRkNmVhYjE3YjY4MzBiMDIyMjYxNWY0MzkxZTM4Zi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/sPV5C1mMG2V2VRbWnalNRYshYMpunlXipkz1D4bCbt4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMGRkNmVhYjE3YjY4MzBiMDIyMjYxNWY0MzkxZTM4Zi9wMDAxLnBuZw" }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/2", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "efee8b4c-4527-4420-ba04-24096ba129b2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to the presenters and the merger", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/3", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "efee8b4c-4527-4420-ba04-24096ba129b2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to the presenters and the merger", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "before_after", "function": "present_solution", "notes": "Uses a before-after-bridge style layout to show the merger rationale.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/4", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-4", "loopMatches": [ { "to": 9, "from": 4, "name": "Tale Two Worlds", "slug": "04-tale-two-worlds", "bestFor": "Competitive analysis, benchmarking, case for change", "matchId": "81509c29-ca74-494c-845f-ce647a7bfd47", "evidence": "Comparison of Neogen and 3M Food Safety", "position": 0, "objective": "To present the benefits of the combination", "structure": "Current State -> Desired State / Benchmark -> The Gap & Implication", "confidence": 0.7, "description": "Show the gap between two states to drive urgency or highlight opportunity" }, { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "efee8b4c-4527-4420-ba04-24096ba129b2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to the presenters and the merger", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "executive_summary", "function": "size_opportunity", "notes": "The slide uses a three-column structure to frame the investment thesis: Market Size/Growth, Tailwinds/Complexity, and Product/Geographic Mix.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/5", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-5", "loopMatches": [ { "to": 9, "from": 4, "name": "Tale Two Worlds", "slug": "04-tale-two-worlds", "bestFor": "Competitive analysis, benchmarking, case for change", "matchId": "81509c29-ca74-494c-845f-ce647a7bfd47", "evidence": "Comparison of Neogen and 3M Food Safety", "position": 0, "objective": "To present the benefits of the combination", "structure": "Current State -> Desired State / Benchmark -> The Gap & Implication", "confidence": 0.7, "description": "Show the gap between two states to drive urgency or highlight opportunity" }, { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "dc833f8b-4e78-4521-86a0-0a109dce55fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Overview of the transaction and key messages", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a structured table-like layout to categorize key deal terms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/6", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-6", "loopMatches": [ { "to": 9, "from": 4, "name": "Tale Two Worlds", "slug": "04-tale-two-worlds", "bestFor": "Competitive analysis, benchmarking, case for change", "matchId": "81509c29-ca74-494c-845f-ce647a7bfd47", "evidence": "Comparison of Neogen and 3M Food Safety", "position": 0, "objective": "To present the benefits of the combination", "structure": "Current State -> Desired State / Benchmark -> The Gap & Implication", "confidence": 0.7, "description": "Show the gap between two states to drive urgency or highlight opportunity" }, { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "dc833f8b-4e78-4521-86a0-0a109dce55fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Overview of the transaction and key messages", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/7", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-7", "loopMatches": [ { "to": 9, "from": 4, "name": "Tale Two Worlds", "slug": "04-tale-two-worlds", "bestFor": "Competitive analysis, benchmarking, case for change", "matchId": "81509c29-ca74-494c-845f-ce647a7bfd47", "evidence": "Comparison of Neogen and 3M Food Safety", "position": 0, "objective": "To present the benefits of the combination", "structure": "Current State -> Desired State / Benchmark -> The Gap & Implication", "confidence": 0.7, "description": "Show the gap between two states to drive urgency or highlight opportunity" }, { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "dc833f8b-4e78-4521-86a0-0a109dce55fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Overview of the transaction and key messages", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/8", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-8", "loopMatches": [ { "to": 9, "from": 4, "name": "Tale Two Worlds", "slug": "04-tale-two-worlds", "bestFor": "Competitive analysis, benchmarking, case for change", "matchId": "81509c29-ca74-494c-845f-ce647a7bfd47", "evidence": "Comparison of Neogen and 3M Food Safety", "position": 0, "objective": "To present the benefits of the combination", "structure": "Current State -> Desired State / Benchmark -> The Gap & Implication", "confidence": 0.7, "description": "Show the gap between two states to drive urgency or highlight opportunity" }, { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "dc833f8b-4e78-4521-86a0-0a109dce55fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Overview of the transaction and key messages", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/9", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-9", "loopMatches": [ { "to": 9, "from": 4, "name": "Tale Two Worlds", "slug": "04-tale-two-worlds", "bestFor": "Competitive analysis, benchmarking, case for change", "matchId": "81509c29-ca74-494c-845f-ce647a7bfd47", "evidence": "Comparison of Neogen and 3M Food Safety", "position": 0, "objective": "To present the benefits of the combination", "structure": "Current State -> Desired State / Benchmark -> The Gap & Implication", "confidence": 0.7, "description": "Show the gap between two states to drive urgency or highlight opportunity" }, { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 5, "beatId": "dc833f8b-4e78-4521-86a0-0a109dce55fa", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Executive Summary", "beatSlug": null, "evidence": "Overview of the transaction and key messages", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a matrix structure to map product categories (Indicator Testing, Hygiene Monitoring, etc.) against revenue metrics and product types (Consumables vs Hardware/Software).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/10", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-10", "loopMatches": [ { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/11", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-11", "loopMatches": [ { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/12", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-12", "loopMatches": [ { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "present_framework", "notes": "The diagram uses a hub-and-spoke circular layout to represent an integrated value chain.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/13", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-13", "loopMatches": [ { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_messages", "function": "summarize", "notes": "Uses a numbered list format to highlight synergy and growth potential.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/14", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-14", "loopMatches": [ { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a comparison-style list format to highlight the value proposition of the merger.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/15", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-15", "loopMatches": [ { "to": 15, "from": 4, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "1bfcb33d-2190-4471-ac35-636f0a9e74b0", "evidence": "Before and after analysis of the merger", "position": 1, "objective": "To show the value of the combination", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses donut charts to visualize revenue segmentation across three business entities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/16", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "establish_context", "notes": "The slide uses a logo-grid layout to demonstrate market reach and credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/17", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a plus sign to indicate the additive nature of the merger.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/18", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "geographic_map", "function": "establish_context", "notes": "The slide uses a legend to categorize locations and highlights specific facility expansions in Lansing and Bridgend.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/19", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a horizontal arrow timeline to represent the progression from pre-signing to post-close.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/20", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "comparison_table", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/21", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The chart uses a stacked bar format to show the contribution of Neogen and 3M Food Safety to total revenue over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/22", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 22, "from": 8, "beatId": "fd8390e7-29fd-4f9d-956c-bc1fe43cb1eb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Benefits of the merger and pro forma financial profile", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a structured table-like layout to categorize synergies into Growth and Cost buckets, mapping specific initiatives to financial outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/23", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-23", "loopMatches": [ { "to": 23, "from": 23, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "ab314c07-c615-4569-8deb-6c952cbfa230", "evidence": "Targeting EBITDA contribution from growth and cost synergies", "position": 2, "objective": "To propose a solution", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 23, "from": 23, "beatId": "20ee2676-f625-4d68-b859-9e797534c2fc", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Propose Solution", "beatSlug": null, "evidence": "Targeting EBITDA contribution from growth and cost synergies", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d677-70d1-a357-51df6625c025", "docSlug": "b0dd6eab17b6830b0222615f4391e38f", "documentTitle": "3M | Mergers and Acquisitions Presentation Deck | 24 slides", "authorId": "3m", "authorName": "Neogen", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d677-70d1-a357-51df6625c025/24", "deckHref": "/decks/019de071-d677-70d1-a357-51df6625c025", "deckAnchorHref": "/decks/019de071-d677-70d1-a357-51df6625c025#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 24, "beatId": "eea784f7-8189-4a1a-8d1a-49d111540cbb", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Key Takeaways", "beatSlug": null, "evidence": "Concluding perspectives", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/38bhTGRBjH30UTE5zlm01SSuGvfsY-urtPOiP2nYfks/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMThjOTlmYzEwZjY3MWZjMzk3ZjhhNzQzY2RjMGNlNC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/1", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/zaU6rFEu-m6LtsIsi7GGgx1XyJb77L3KK0241GTgqkM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMThjOTlmYzEwZjY3MWZjMzk3ZjhhNzQzY2RjMGNlNC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/SecoK0Nl_HVZO_AU4kbGeW1-OdT_iqXxm5Oobvjxwpo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMThjOTlmYzEwZjY3MWZjMzk3ZjhhNzQzY2RjMGNlNC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/0FfY5b1wbfLoI4V5NbYlI1w4Ijtv3r1ZstJkYKgtPVA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMThjOTlmYzEwZjY3MWZjMzk3ZjhhNzQzY2RjMGNlNC9wMDAxLnBuZw" }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/2", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "closing_ask", "function": "summarize", "notes": "The slide features three photos representing the research team, clinical collaboration, and the patient community.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/3", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/4", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a structured layout to present three key pillars of clinical success: efficacy, functional outcome, and safety.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/5", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-5", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the clinical trial phases (randomization, treatment, extension).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/6", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-6", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/7", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-7", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays mean, standard deviation, median, and range for various clinical metrics including Plasma Arginine, GMFCS level, GMFM-E, and 2MWT.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/8", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-8", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart is a box-and-whisker plot comparing pegzilarginase and placebo groups against clinical guidelines and normal ranges.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/9", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-9", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Clinical trial data showing efficacy of pegzilarginase.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/10", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-10", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 10, "from": 5, "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "other", "function": "present_framework", "notes": "The slide contrasts unaided mobility assessment (GMFM) with aided mobility assessment (2-Minute Walk Test).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/11", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-11", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "before_after", "function": "analyze_data", "notes": "GMFM-E refers to Gross Motor Function Measure, dimension E (walking, running, jumping).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/12", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-12", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart shows positive improvement for Pegzilarginase at both time points, while Placebo shows a decline at 12 weeks and slight improvement at 24 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/13", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-13", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a clear comparison table to demonstrate safety outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/14", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-14", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-part structure to summarize clinical trial outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/15", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-15", "loopMatches": [ { "to": 15, "from": 5, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f", "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.", "position": 1, "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-column layout to categorize program strengths.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/16", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "problem_statement", "function": "diagnose_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/17", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-17", "loopMatches": [ { "to": 18, "from": 17, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4c241dda-0f46-4b49-a593-48cefd4422b6", "evidence": "Emphasizes the need for a solution by highlighting current limitations.", "position": 0, "objective": "Highlights the cost of not addressing ARG1-D effectively", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 17, "from": 17, "beatId": "f8d657a3-54b1-4949-a0ca-29bf8682795e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slide highlights the lack of effective treatments for ARG1-D.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 18, "from": 17, "beatId": "a86c9ca1-cc85-479e-8c1a-21e60e6a73da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides emphasize the impact of unmanaged arginine levels on patients.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "market_sizing", "function": "size_opportunity", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/18", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-18", "loopMatches": [ { "to": 18, "from": 17, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4c241dda-0f46-4b49-a593-48cefd4422b6", "evidence": "Emphasizes the need for a solution by highlighting current limitations.", "position": 0, "objective": "Highlights the cost of not addressing ARG1-D effectively", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 18, "from": 17, "beatId": "a86c9ca1-cc85-479e-8c1a-21e60e6a73da", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides emphasize the impact of unmanaged arginine levels on patients.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/19", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/20", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "roadmap", "function": "present_solution", "notes": "The slide uses a Gantt-style chart to represent clinical trial phases for different drug programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/21", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/22", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d756-7568-8588-410684bab010", "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4", "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/23", "deckHref": "/decks/019de071-d756-7568-8588-410684bab010", "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes footnotes for data reconciliation and methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/9", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-9", "loopMatches": [ { "to": 14, "from": 8, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "15b63c85-f70f-41b2-ad9d-197078f80bb9", "evidence": "The company presents its financial data and analysis, which has implications for investors and analysts.", "position": 1, "objective": "What are the implications of our financial performance?", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "c1bf6ea0-14b0-41fc-8154-929589aa7369", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The company provides detailed financial information, including KPIs and Non-GAAP financial data.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-style bridge to show growth and donut charts for segment composition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/10", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-10", "loopMatches": [ { "to": 14, "from": 8, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "15b63c85-f70f-41b2-ad9d-197078f80bb9", "evidence": "The company presents its financial data and analysis, which has implications for investors and analysts.", "position": 1, "objective": "What are the implications of our financial performance?", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "c1bf6ea0-14b0-41fc-8154-929589aa7369", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The company provides detailed financial information, including KPIs and Non-GAAP financial data.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights revenue growth and take rate stability post-IPO.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/11", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-11", "loopMatches": [ { "to": 14, "from": 8, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "15b63c85-f70f-41b2-ad9d-197078f80bb9", "evidence": "The company presents its financial data and analysis, which has implications for investors and analysts.", "position": 1, "objective": "What are the implications of our financial performance?", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "c1bf6ea0-14b0-41fc-8154-929589aa7369", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The company provides detailed financial information, including KPIs and Non-GAAP financial data.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses bar charts to show growth metrics and highlights key drivers for SG&A and EBITDA changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/12", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-12", "loopMatches": [ { "to": 14, "from": 8, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "15b63c85-f70f-41b2-ad9d-197078f80bb9", "evidence": "The company presents its financial data and analysis, which has implications for investors and analysts.", "position": 1, "objective": "What are the implications of our financial performance?", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "c1bf6ea0-14b0-41fc-8154-929589aa7369", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The company provides detailed financial information, including KPIs and Non-GAAP financial data.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide includes a disclaimer note on the right side regarding revenue recognition net of taxes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/13", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-13", "loopMatches": [ { "to": 14, "from": 8, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "15b63c85-f70f-41b2-ad9d-197078f80bb9", "evidence": "The company presents its financial data and analysis, which has implications for investors and analysts.", "position": 1, "objective": "What are the implications of our financial performance?", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "c1bf6ea0-14b0-41fc-8154-929589aa7369", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The company provides detailed financial information, including KPIs and Non-GAAP financial data.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-like logic to explain margin expansion via operating leverage and corporate structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/14", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-14", "loopMatches": [ { "to": 14, "from": 8, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "15b63c85-f70f-41b2-ad9d-197078f80bb9", "evidence": "The company presents its financial data and analysis, which has implications for investors and analysts.", "position": 1, "objective": "What are the implications of our financial performance?", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 0.6, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "c1bf6ea0-14b0-41fc-8154-929589aa7369", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The company provides detailed financial information, including KPIs and Non-GAAP financial data.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 15, "from": 14, "beatId": "389b66b4-db84-4b97-ad76-a4fa4bde8e44", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The company presents its net margin expansion and Q&A section, which provides satisfaction to the audience.", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "closing_ask", "function": "closing_ask", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/15", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 14, "beatId": "389b66b4-db84-4b97-ad76-a4fa4bde8e44", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The company presents its net margin expansion and Q&A section, which provides satisfaction to the audience.", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/16", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/17", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Financial disclosure slide showing non-GAAP adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/18", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table uses a waterfall-style logic to subtract columns [B], [C], and [D] from [A] to reach the final adjusted figures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/19", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes YoY and QoQ growth metrics for financial adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/20", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-d5da-7722-b5ab-539e7001d5ce", "docSlug": "3f12ed75624112e2de67f8e5ded5d0d5", "documentTitle": "XP Inc | Results Presentation Deck | 21 slides", "authorId": "xp-inc", "authorName": "XP Inc.", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-style bridge to show percentage growth between two periods for two distinct business units.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-d5da-7722-b5ab-539e7001d5ce/21", "deckHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce", "deckAnchorHref": "/decks/019de071-d5da-7722-b5ab-539e7001d5ce#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }